We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+4.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.04B
AUM Growth
+$73M
(+1.2%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-2.38%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
1,047
New
173
Increased
233
Reduced
390
Closed
225
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$50M |
| 2 |
Merck
MRK
|
+$46.7M |
| 3 |
Cognizant
CTSH
|
+$37.2M |
| 4 |
Las Vegas Sands
LVS
|
+$25.6M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$51.6M |
| 2 |
Comcast
CMCSA
|
+$48.7M |
| 3 |
Intel
INTC
|
+$38.4M |
| 4 |
Amazon
AMZN
|
+$38.4M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
+$36.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.81% |
| 2 | Industrials | 13.63% |
| 3 | Financials | 13.56% |
| 4 | Healthcare | 12.66% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MERU
726
DELISTED
MERU NETWORKS INC COM STK (DE)
MERU
| $277K | ﹤0.01% |
75,294
-84,300
| -53% | -$332K |
|
727
Lifetime Brands
LCUT
$199M
| $274K | ﹤0.01% |
+17,412
| New | +$287K |
|
|
BFS
728
Saul Centers
BFS
$875M
| $273K | ﹤0.01% |
5,619
-1,600
| -22% | -$75.8K |
|
|
HILL
729
DELISTED
DOT HILL SYSTEMS CORP
HILL
| $272K | ﹤0.01% |
57,959
-16,600
| -22% | -$68.1K |
|
|
IVC
730
DELISTED
Invacare Corporation
IVC
| $270K | ﹤0.01% |
+14,700
| New | +$250K |
|
731
ANI Pharmaceuticals
ANIP
$1.77B
| $267K | ﹤0.01% |
7,759
-1,580
| -17% | -$49.5K |
|
|
BEBE
732
DELISTED
Bebe Stores Inc
BEBE
| $266K | ﹤0.01% |
8,710
+1,830
| +27% | +$84.8K |
|
|
DEST
733
DELISTED
Destination Maternity Corporation
DEST
| $265K | ﹤0.01% |
11,647
-4,500
| -28% | -$110K |
|
734
Under Armour
UAA
$3B
| $261K | ﹤0.01% |
8,822
-159,287
| -95% | -$4.15M |
|
735
First Business Financial Services
FBIZ
$562M
| $256K | ﹤0.01% |
+10,900
| New | +$252K |
|
736
Universal Insurance Holdings
UVE
$1.16B
| $256K | ﹤0.01% |
19,700
-3,100
| -14% | -$40.8K |
|
|
ELX
737
DELISTED
EMULEX CORP
ELX
| $254K | ﹤0.01% |
44,480
-824,014
| -95% | -$4.9M |
|
|
RENT
738
DELISTED
RENTRAK CORP
RENT
| $246K | ﹤0.01% |
4,690
-5,530
| -54% | -$293K |
|
739
Usana Health Sciences
USNA
$394M
| $245K | ﹤0.01% |
6,280
+600
| +11% | +$22.3K |
|
|
SYKE
740
DELISTED
SYKES Enterprises Inc
SYKE
| $243K | ﹤0.01% |
11,167
| – | – |
|
|
AOI
741
DELISTED
Alliance One International
AOI
| $240K | ﹤0.01% |
9,615
-6,276
| -39% | -$165K |
|
742
WSFS Financial
WSFS
$4.1B
| $239K | ﹤0.01% |
9,750
-11,700
| -55% | -$272K |
|
|
DSPG
743
DELISTED
DSP Group Inc
DSPG
| $238K | ﹤0.01% |
28,006
| – | – |
|
744
REX American Resources
REX
$1.46B
| $234K | ﹤0.01% |
19,158
-4,200
| -18% | -$46.2K |
|
745
Patrick Industries
PATK
$2.8B
| $230K | ﹤0.01% |
16,673
-5,197
| -24% | -$62.5K |
|
746
Woodward
WWD
$25B
| $229K | ﹤0.01% |
+4,570
| New | +$208K |
|
|
ALX
747
Alexander's
ALX
$1.4B
| $228K | ﹤0.01% |
617
-716
| -54% | -$257K |
|
|
MFI
748
DELISTED
MICROFINANCIAL INC
MFI
| $228K | ﹤0.01% |
29,493
-2,991
| -9% | -$23.5K |
|
|
OCLR
749
DELISTED
Oclaro Inc.
OCLR
| $227K | ﹤0.01% |
103,300
| – | – |
|
|
DYAX
750
DELISTED
DYAX CORPORATION
DYAX
| $226K | ﹤0.01% |
23,500
+8,400
| +56% | +$64K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2014 Portfolio in Review
As of Q2 2014, Jacobs Levy Equity Management held 1,047 positions worth $6.04B, up 1.2% from $5.97B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q2 2014 filing shows 173 new, 233 increased, 390 reduced and 225 closed positions. Its largest new stake was Merck: 856,750 shares worth $47.3M. The largest sale was DIRECTV COM STK (DE), an estimated $51.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.
- Jacobs Levy Equity Management's largest Q2 2014 buy was Merck: 856,750 shares worth $47.3M.
- Jacobs Levy Equity Management added most to Pfizer in Q2 2014, an estimated $50M increase.
- Jacobs Levy Equity Management's biggest Q2 2014 reduction was Comcast, cutting an estimated $48.7M.
- Jacobs Levy Equity Management fully exited DIRECTV COM STK (DE) in Q2 2014, selling an estimated $51.6M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $6.04B portfolio in Q2 2014.
- Jacobs Levy Equity Management opened 173 new positions and closed 225 in Q2 2014.
- Jacobs Levy Equity Management's portfolio value rose 1.2% quarter-over-quarter to $6.04B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2014, filed 14 Aug 2014.